Skip to content

Evaluation of the Dental Vibe Injection Comfort System

Evaluation of the Dental Vibe Injection Comfort System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04971941
Acronym
DVRCT
Enrollment
60
Registered
2021-07-22
Start date
2015-04-30
Completion date
2015-11-30
Last updated
2023-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Pain

Keywords

Anesthesia, local, Pain

Brief summary

This study investigated the Dental Vibe Injection Comfort System (DV), developed to lessen anesthesia pain through pulsed vibration, a form of counter-stimulation. The study's aims were to evaluate DV's efficacy in reducing pain/discomfort from intra-oral long buccal (LB) and inferior alveolar nerve (IAN) injections and the time needed to achieve complete anesthesia during an IAN block.

Detailed description

Objective: Pain from local anesthesia injections can be reduced by distraction and counter-stimulation techniques. This study investigated the Dental Vibe Injection Comfort System (DV), developed to lessen anesthesia pain through pulsed vibration, a form of counter-stimulation. Design: Our study's aims were to evaluate DV's efficacy in reducing pain/discomfort from intra-oral long buccal (LB) and inferior alveolar nerve (IAN) injections and the time needed to achieve complete anesthesia during an IAN block. Methods: The sixty subjects, equally split by sex, ages 21-32, rated injection pain on a visual analog scale and discomfort, unpleasantness, and difficulty in enduring the injection on a modified symptom severity index. Each subject received bilateral LB injections and an IAN block. Using block design, DV Generation 3 (DV3) was randomly assigned to either the first or second LB injection and to thirty subjects on their third injection, the IAN block. No topical anesthesia was applied.

Interventions

Use of Dental Vibe during dental anesthesia intervention

Sponsors

Harvard Medical School (HMS and HSDM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Able to volunteer for dental anesthesia -

Exclusion criteria

Non volunteer \-

Design outcomes

Primary

MeasureTime frameDescription
VASMeasured during anesthesia procedure by the subject and recorded after each individual anesthesia procedure, an average of one minuteVAS (visual analog scale) measured pain during anesthesia procedure on a scale from 0-10 with 0 being no pain and 10 being the most intense pain. The lowest number is the best outcome.

Secondary

MeasureTime frameDescription
SSImeasured by subject during procedure but recorded directly after each procedureSSI measured tolerability, intensity, and unpleasantness of anesthesia procedure. Each has a scale from 0-28; with 0 being the least discomfort, least intolerable, and lowest intensity; whereas 28 is the most discomfort, most intolerable, and most intense.
Time in MinutesAfter procedure until lip numbness, an average of four minutesTime for complete inferior alveolar nerve block anesthesia with or without use of Dental Vibe measured in minutes. The time was recorded in minutes from when the anesthesia procedure was completed until the subject had a numb lip and could no longer feel cold (ice) applied to their ipsilateral canine tooth

Participant flow

Recruitment details

A total of 60 subjects participated in this study. Each participant had 3 procedures done (bilateral buccal nerve blocks one with or without the use of Dentalvibe, and then one inferior alveolar nerve (IAN) block for which 30 subjects had it done with the Dentalvibe and 30 subjects had it done without the use of the Dentalvibe. The IAN blocks with or w/o the Dentalvibe was chosen randomly.and which side went first with or without the Dentalvibe was also chosen randomly.

Participants by arm

ArmCount
DV3 With 1st LB Injection
DV3 with First Long Buccal Use of Dental Vibe during dental anesthesia intervention
15
DV3 With 1st LB Injection and IAN Block (3rd Injection)
Dental Vibe with first long buccal injection and IAN Dental Vibe: Use of Dental Vibe during dental anesthesia intervention
15
DV3 With 2nd LB Injection
DV3 with 2nd Long Buccal Injection Dental Vibe: Use of Dental Vibe during dental anesthesia intervention
15
DV3 With 2nd LB Injection and DV3 With 2nd LB and IAN Injections
DV3 with 2nd Long Buccal Injection and also with Inferior Alveolar injection
15
Total60

Baseline characteristics

CharacteristicDV3 With 1st LB Injection and IAN Block (3rd Injection)DV3 With 2nd LB InjectionDV3 With 2nd LB Injection and DV3 With 2nd LB and IAN InjectionsDV3 With 1st LB InjectionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants15 Participants15 Participants15 Participants60 Participants
Age, Continuous24 years
STANDARD_DEVIATION 1
27 years
STANDARD_DEVIATION 1.5
26 years
STANDARD_DEVIATION 1
23 years
STANDARD_DEVIATION 1.5
25 years
STANDARD_DEVIATION 1.25
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
15 Participants15 Participants15 Participants15 Participants60 Participants
Sex: Female, Male
Female
8 Participants8 Participants7 Participants7 Participants30 Participants
Sex: Female, Male
Male
7 Participants7 Participants8 Participants8 Participants30 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 150 / 150 / 150 / 600 / 300 / 30
other
Total, other adverse events
0 / 150 / 150 / 150 / 150 / 600 / 300 / 30
serious
Total, serious adverse events
0 / 150 / 150 / 150 / 150 / 600 / 300 / 30

Outcome results

Primary

VAS

VAS (visual analog scale) measured pain during anesthesia procedure on a scale from 0-10 with 0 being no pain and 10 being the most intense pain. The lowest number is the best outcome.

Time frame: Measured during anesthesia procedure by the subject and recorded after each individual anesthesia procedure, an average of one minute

Population: Subjects getting IAN with or without DV, LB with DV used first, LB with DV used second

ArmMeasureGroupValue (MEAN)Dispersion
Inferior Alveolar BlockVASwith dental vibe2.5 score on a scaleStandard Deviation 1.48
Inferior Alveolar BlockVASwithout dental vibe4.2 score on a scaleStandard Deviation 2.17
LB Injection With DV FirstVASwith dental vibe2.3 score on a scaleStandard Deviation 1.21
LB Injection With DV FirstVASwithout dental vibe3.3 score on a scaleStandard Deviation 1.75
Long Buccal Injection With DV SecondVASwith dental vibe2.7 score on a scaleStandard Deviation 1.46
Long Buccal Injection With DV SecondVASwithout dental vibe4.0 score on a scaleStandard Deviation 1.74
Comparison: Sample size estimation from Nanitsos 2010: Using the P value from the paired T test with 61 degrees of freedom the T statistic calculated at 4.365. From mean difference 9.3 SD was calculated as 16.66 for an effect size of 0.558. This generated a sample size of 44 subjects, receiving 2 injections (1 with DV3 and 1 without), is necessary to attain 95% power for a paired t-test comparing the 2 pain measures at a two-tailed alpha level of 0.05. P value for IANp-value: 0.00195% CI: [0.4, 2.1]t-test, 2 sided
p-value: 0.0295% CI: [-1.7, -1.5]t-test, 2 sided
p-value: 0.00495% CI: [0.4, 2.1]t-test, 2 sided
Secondary

SSI

SSI measured tolerability, intensity, and unpleasantness of anesthesia procedure. Each has a scale from 0-28; with 0 being the least discomfort, least intolerable, and lowest intensity; whereas 28 is the most discomfort, most intolerable, and most intense.

Time frame: measured by subject during procedure but recorded directly after each procedure

Population: scale from 0-28 with zero being non discomfort, completely tolerable, no unpleasantness

ArmMeasureGroupValue (MEAN)Dispersion
Inferior Alveolar BlockSSIwith dental vibe4.8 score on a scaleStandard Deviation 3.02
Inferior Alveolar BlockSSIwithout dental vibe8.9 score on a scaleStandard Deviation 5.67
LB Injection With DV FirstSSIwith dental vibe6.2 score on a scaleStandard Deviation 4.31
LB Injection With DV FirstSSIwithout dental vibe10.2 score on a scaleStandard Deviation 5.42
Long Buccal Injection With DV SecondSSIwith dental vibe5.8 score on a scaleStandard Deviation 4.04
Long Buccal Injection With DV SecondSSIwithout dental vibe9.8 score on a scaleStandard Deviation 5.9
SSI Tolerability LB Block DV FirstSSIwith dental vibe4.0 score on a scaleStandard Deviation 3.23
SSI Tolerability LB Block DV FirstSSIwithout dental vibe6.0 score on a scaleStandard Deviation 4.66
SSI Tolerabilty Long Buccal Block DV SecondSSIwith dental vibe5.0 score on a scaleStandard Deviation 3.77
SSI Tolerabilty Long Buccal Block DV SecondSSIwithout dental vibe7.6 score on a scaleStandard Deviation 4.72
SSI Discomfort LB DV FirstSSIwithout dental vibe7.9 score on a scaleStandard Deviation 4.21
SSI Discomfort LB DV FirstSSIwith dental vibe5.3 score on a scaleStandard Deviation 3.04
SSI Discomfort LB DV SecondSSIwithout dental vibe9.1 score on a scaleStandard Deviation 4.06
SSI Discomfort LB DV SecondSSIwith dental vibe6.8 score on a scaleStandard Deviation 4.5
SSI Unpleasantness LB With DV FirstSSIwith dental vibe5.3 score on a scaleStandard Deviation 3.51
SSI Unpleasantness LB With DV FirstSSIwithout dental vibe7.6 score on a scaleStandard Deviation 4.67
SSI Unpleasantness LB DV SecondSSIwith dental vibe6.5 score on a scaleStandard Deviation 4.36
SSI Unpleasantness LB DV SecondSSIwithout dental vibe8.8 score on a scaleStandard Deviation 4.6
p-value: 0.00114% CI: [0.4, 4.8]t-test, 2 sided
p-value: 0.003t-test, 2 sided
p-value: 0.003t-test, 2 sided
p-value: 0.058t-test, 2 sided
p-value: 0.008t-test, 2 sided
p-value: 0.044t-test, 2 sided
p-value: 0.023t-test, 2 sided
p-value: 0.042t-test, 2 sided
p-value: 0.053t-test, 2 sided
Secondary

Time in Minutes

Time for complete inferior alveolar nerve block anesthesia with or without use of Dental Vibe measured in minutes. The time was recorded in minutes from when the anesthesia procedure was completed until the subject had a numb lip and could no longer feel cold (ice) applied to their ipsilateral canine tooth

Time frame: After procedure until lip numbness, an average of four minutes

Population: time to complete mandibular anesthesia was measured

ArmMeasureGroupValue (MEAN)Dispersion
Inferior Alveolar BlockTime in Minuteswith Dentalvibe6 minutesStandard Deviation 5
Inferior Alveolar BlockTime in Minuteswithout DentalVibe7.8 minutesStandard Deviation 5.6
Comparison: The null hypothesis is that there is no relation between use of DV and numb times. There were no studies from which to perform a power calculation for this outcome measurep-value: 0.459t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026